Influenza vaccine safety data – Aboriginal and Torres Strait Islander participants (all ages)

Australia’s active vaccine safety system

Influenza vaccines

Data on this page show the responses of Aboriginal and Torres Strait Islander people (or their parent/carer) who received an influenza vaccine and completed an AusVaxSafety survey sent in the days following vaccination.

The influenza vaccines currently in use for Aboriginal and Torres Strait Islander people include:

Standard influenza vaccines

Afluria® Quad (individuals aged 5 years and older)
Fluarix Tetra® (individuals aged 6 months and older)
Flucelvax® Quad (individuals aged 6 months and older)
FluQuadri® (individuals aged 6 months and older)
Influvac® Tetra (individuals aged 6 months and older)
Vaxigrip Tetra® (individuals aged 6 months and older).

Adjuvanted or high-dose vaccines

Fluad® Quad (individuals aged 65 years and over)
Fluzone® High-Dose Quad (individuals aged 60 years and over).

These data provide a profile of what to expect in the days following your influenza vaccination and can assist in planning for vaccination.

Data on this page will be updated weekly throughout the 2024 influenza season.

AusVaxSafety's active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration.

Further information on the influenza vaccines can be found at the links below:

2024 influenza (flu) vaccination – consumer fact sheet – Australian Government Department of Health and Aged Care influenza vaccine information for consumers
2024 influenza vaccination – program advice for health professionals – Australian Government Department of Health and Aged Care
Influenza immunisation – NCIRS
Statement on the administration of seasonal influenza vaccines in 2024 – Australian Technical Advisory Group on Immunisation (ATAGI)

Last updated April 2024

Influenza vaccines

Shingrix® vaccine safety data now available

AusVaxSafety receives funding
from the Australian Government

NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090

We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.

We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.

Influenza vaccine safety data – Aboriginal and Torres Strait Islander participants (all ages)

Influenza vaccines

Influenza vaccines

News & events

AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines

Vaccine safety in Australia AusVaxSafety summary report now available

What to expect in the days after your XBB.1.5 COVID-19 vaccine

Shingrix® vaccine safety data now available

Subscribe to our newsletter for immunisation professionals

Subscribe to our newsletter for immunisation professionals